Image: The Epoch TimesWhat Was the FDA Thinking?
• Pharmaceutical journalist Maryanne Demasi has uncovered significant anomalies in the trial data for mRNA vaccines. • The findings, sourced from the FDA's depository and the New England Journal of Medicine, suggest the trials relied on questionable assumptions and imprecisions. • This investigation challenges the FDA's approval process, raising concerns about the safety and efficacy of the deployed mRNA technology.
theepochtimes.com





